Found 4 matching trials
Multiple Donor Treg DLI for Severe Refractory Chronic GVHD
PHASE1This is a INTERVENTIONAL TRANSPLANTATION STUDY WITHOUT DRUGS.
The INTERVEN...
Location
University Hospital St. Orsola-Malpighi Polyclinic
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
PHASE1The purpose of the study is to determine the safety of an investigational t...
Location
Moffitt Cancer Center
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
PHASE1Primary Objectives:
This a pilot project to determine the feasibility of t...
Location
Department of Hematology-Oncology, National University Hospital
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers
PHASE1In this study, haploidentical relatives of a patient with recurrent or meta...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins